I-MAB completed a workforce reduction as part of a Realignment Plan aimed at optimizing its operations following the pipeline reprioritization. The company reduced its workforce by approximately 27% ...

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

According to CEO: ‘Demand across the industry not meeting our expectations.’ ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...

CS Analytical Laboratory, an FDA-regulated contract laboratory dedicated to providing regulatory solutions and qualification ...

Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has opened its Center of Excellence for ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, ...